Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.8250
+0.0243 (3.03%)
At close: Oct 5, 2026, 4:00 PM EDT
0.8224
-0.0026 (-0.32%)
After-hours: Oct 5, 2026, 7:31 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $71.17 million as of October 5, 2026. Its market cap has increased by 156.93% in one year.
Market Cap
71.17M
Enterprise Value
30.52M
1-Year Change
156.93%
Ranking
Category
Stock Price
$0.83
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $71.17M, a decrease of -55.21%. That is a compound annual growth rate of -8.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 71.17M | 133.35% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 72.38M |
| iBio, Inc. | 72.35M |
| RenovoRx | 71.30M |
| Aldeyra Therapeutics | 70.58M |
| Adicet Bio | 69.97M |
| Spero Therapeutics | 69.30M |
| Cingulate | 69.22M |
| Champions Oncology | 68.76M |